Clinical Trial Detail

NCT ID NCT04075747
Title A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid Leukemia (V-FAST)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Jazz Pharmaceuticals
Indications

acute myeloid leukemia

Therapies

CPX-351 + Enasidenib

CPX-351 + Venetoclax

CPX-351 + Midostaurin

Age Groups: senior adult

Additional content available in CKB BOOST